A detailed history of Personal Capital Advisors Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Personal Capital Advisors Corp holds 3,237 shares of NVO stock, worth $340,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,237
Previous 3,644 11.17%
Holding current value
$340,079
Previous $363,000 20.66%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $41,737 - $55,079
-407 Reduced 11.17%
3,237 $438,000
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $23,915 - $29,349
251 Added 7.4%
3,644 $363,000
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $5,162 - $6,090
50 Added 1.5%
3,393 $378,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $64,983 - $78,552
-698 Reduced 17.27%
3,343 $371,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $34,420 - $42,031
359 Added 9.75%
4,041 $453,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $10,468 - $13,220
124 Added 3.49%
3,682 $354,000
Q2 2021

Aug 11, 2021

SELL
$67.66 - $84.76 $63,329 - $79,335
-936 Reduced 20.83%
3,558 $298,000
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $174,423 - $197,207
-2,601 Reduced 36.66%
4,494 $303,000
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $35,139 - $40,590
550 Added 8.4%
7,095 $496,000
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $96,872 - $106,804
1,521 Added 30.27%
6,545 $454,000
Q2 2020

Aug 12, 2020

SELL
$58.54 - $67.94 $35,006 - $40,628
-598 Reduced 10.64%
5,024 $329,000
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $30,022 - $39,321
-607 Reduced 9.74%
5,622 $337,000
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $106,550 - $124,501
2,137 Added 52.22%
6,229 $361,000
Q3 2019

Nov 07, 2019

BUY
$47.54 - $53.43 $194,533 - $218,635
4,092 New
4,092 $211,000
Q1 2019

May 13, 2019

SELL
$46.36 - $52.63 $277,371 - $314,885
-5,983 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$41.54 - $47.25 $248,533 - $282,696
5,983 New
5,983 $276,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Personal Capital Advisors Corp Portfolio

Follow Personal Capital Advisors Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.